Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy

Indian Heart Journal

Volumn 65, Issue 1, 2013, Pages 12-16

  Fan, Kuan Lu ^a,b   Zhang, Hai Feng ^a   Shen, Jie ^a   Zhang, Qi ^a   Li, Xin Li ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Biomarkers; Dilated cardiomyopathy; Heart failure; MicroRNA

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MICRORNA; MICRORNA 126; MICRORNA 146A; MICRORNA 155; MICRORNA 361; MICRORNA 423; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CHINESE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PURIFICATION; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANALYSIS OF VARIANCE; CARDIOMYOPATHY, DILATED; CHI-SQUARE DISTRIBUTION; FEMALE; HEART FAILURE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; ROC CURVE;

EID: 84874542644     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ihj.2012.12.022     Document Type: Article

References (20)

1. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
2. S.K. Gupta, C. Bang, and T. Thum Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease Circ Cardiovasc Genet 3 2010 484 488
3. M. Satoh, Y. Minami, and Y. Takahashi A cellular microRNA, let-7i, is a novel biomarker for clinical outcome in patients with dilated cardiomyopathy J Card Fail 17 2011 923 929
4. T. Horie, K. Ono, and H. Nishi Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway Cardiovasc Res 87 2010 656 664
5. T. Thum, P. Galuppo, and C. Wolf MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure Circulation 116 2007 258 267
6. P. Richardson, W. McKenna, and M. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies Circulation 93 1996 841 842
7. E.M. Kroh, R.K. Parkin, and P.S. Mitchell Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) Methods 50 2010 298 301
8. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408
9. A.J. Tijsen, E.E. Creemers, and P.D. Moerland MiR423-5p as a circulating biomarker for heart failure Circ Res 106 2010 1035 1039
10. Y. Goren, M. Kushnir, and B. Zafrir Serum levels of microRNAs in patients with heart failure Eur J Heart Fail 14 2012 147 154
11. Y. Fukushima, M. Nakanishi, and H. Nonogi Assessment of plasma miRNAs in congestive heart failure Circ J 75 2011 336 340
12. C. Chen, S.L. Yang, and F. Wang Plasma microRNA-361-5p as a biomarker of chronic heart failure Heart 2010 A189
13. A. Zampetaki, S. Kiechl, and I. Drozdov Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes Circ Res 107 2010 810 817
14. S. Fichtlscherer, S. De Rosa, and H. Fox Circulating microRNAs in patients with coronary artery disease Circ Res 107 2010 677 684
15. J.V. Schou, K.K. Andersen, and B.V. Jensen Prediction of survival in patients with metastatic colorectal cancer treated with third-line cetuximab and irinotecan through changes in microRNA expression in whole blood during treatment J Clin Oncol 29 15 suppl 2011 abstr 3532
16. K.U. Kotlo, B. Hesabi, and R.S. Danziger Implication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cells Am J Physiol Cell Physiol 301 2011 C929 C937
17. O. Tutarel, S. Dangwal, and J. Bretthauer Circulating miR-423-5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries Int J Cardiol 2011 Dec 20 Epub (ahead of print)
18. S.R. Quinn, and L.A. O'Neill A trio of microRNAs that control Toll-like receptor signalling Int Immunol 23 2011 421 425
19. P.A. da Costa Martins, M. Bourajjaj, and M. Gladka Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling Circulation 118 2008 1567 1576
20. M.F. Corsten, B. Schroen, and M. Van De Vrie Absence of microRNA-155 protects against adverse cardiac inflammation and hypertrophy during pressure overload and prevents heart failure Eur J Heart Fail Supplements 10 2011 S5 S6